Hold RTX at 80-85% residual; binding 9/29 reflection prohibits T1 deployment into stacked resistance and negative MACD with imminent earnings
HOLD is the binding decision. The 9/29 reflection explicitly prohibits T1 deployment when overhead resistance, negative MACD, and imminent earnings align—all three conditions are present today. BUY/OVERWEIGHT is rejected due to the binding lesson, the market's honest verdict on the AMRAAM headline making new lows, and ATR contraction being symmetric rather than asymmetric bullish. UNDERWEIGHT is rejected because the 9/28 reflection explicitly warns against marginal trims that inherit the worst of both worlds; after four trims already (9/14, 9/15, 9/17, 9/18), another 10-15% trim crystallizes marginal alpha (-0.1% to -0.2%) without committing decisively. HOLD preserves 80-85% exposure to multi-year structural compounding (margin expansion 8.2% → 11.4%, $289B backlog, $9.88B FCF) while avoiding both the 9/29 front-loaded T1 failure mode and the 9/28 marginal trim failure mode. Price target $215.00.
| Position | Action |
|---|---|
| Current position | Maintain 80-85% residual exposure; prohibit adding at $185.65 |
| Confirmed close <$184.54 on volume >3.5M | Escalate to Underweight with 25-30% trim (commits decisively per 9/28 reflection) |
| Confirmed close >$193.75 with volume >3.5M AND RSI >40 | Tactical add back ~10% toward 90-95% of pre-trim size |
| No further marginal trims at current configuration | 9/28 reflection explicitly warns against worst-of-both-worlds outcome from incremental 10-15% trim |
| No chasing rallies to $207-210 without volume >4M confirmation | That zone is overhead resistance, not add zone |
| Hard close below $178.50 | Execute mechanical stop on residual position below lower Bollinger Band extension; no renegotiation |
RTX's pullback to $185.65 is a gift, not a warning — driven by record Q2 2026 fundamentals, a $20.7B AMRAAM contract, expanding margins, declining debt, and geopolitical tailwinds that make this a compelling long at current levels.
| Indicator | Value | Signal |
|---|---|---|
| Close | 185.65 | bearish |
| 50 SMA | 206.97 | bearish |
| 200 SMA | 193.75 | bearish |
| MACD | -5.39 | bearish |
| RSI | 25.13 | bearish |
| Bollinger Middle | 194.34 | neutral |
| Bollinger Upper | 204.15 | neutral |
| Bollinger Lower | 184.54 | neutral |
| ATR | 3.84 | neutral |
| Open | 186.38 | neutral |
| High | 187.54 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Escalate to Underweight with 25-30% trim (commits decisively per 9/28 reflection)
Massive $20.7B AMRAAM contract win demonstrates institutional accumulation during weakness
· concedes: Bear's TTM P/E of 32.7x is technically accurate for trailing earnings, though it reflects 2023 trough margins from GTF recall, not current fundamentals; Short-side risk exists if geopolitical ceasefire expectations materialize; Rising 30-year Treasury yields at highest level since 2002 and mortgage rates at 7.58% create macro headwinds for rate-sensitive sectors
RTX is a fundamentally improving company whose stock is technically breaking down at a hostile macro moment, with valuation already pricing in much of the good news—the entry point is poor and waiting for a cleaner setup (below $170) is the disciplined approach.
· concedes: Q2 2026 was a record quarter; Operating margin has expanded from 5.2% (2023) to 11.4% (Q2 2026); AMRAAM contract has real value (incremental $300-400M/year in operating profit); 200 SMA ($193.75) is still above its March 2026 level of $171.50 (trailing momentum); Deficit spending provides some long-term defense spending support; Zero retail interest means no crowd-chasing at these levels
→ vs conservative: Technical damage (50 SMA rolling over, MACD negative 21 sessions, price below moving averages) is a lagging indicator reacting to rational pullback after 46% rally from $155 to $226, not a breakdown signal
→ vs conservative: TTM P/E of 32.7x is the wrong lens; forward P/E of 23.65x below S&P 500 average for a name with 38% earnings growth is mispriced, not expensive
→ vs conservative: Macro concerns about 30-year Treasury yields and 97% probability of no rate cuts are non-sequiturs for a 0.29 beta stock with locked-in multi-year backlog
→ vs conservative: RSI at 25 is statistically rare for a defense name with RTX's structural profile and represents an exhaustion signal, not a warning
→ vs neutral: Waiting for RSI to tick above 30 or daily close above 50 SMA at $207 means missing the first 8% of the move into resistance
→ vs neutral: High-conviction analysis means identifying asymmetric setups before they become consensus, not waiting for confirmation
→ vs neutral: Zero Reddit posts is not a warning sign but evidence of institutionally-led price discovery, which makes rallies more durable
| Low | 184.56 | bearish |
| Volume | 4,641,328 | neutral |
Support: 184.54 | Resistance: 193.75 · 194.34 · 204.15 · 206.97
RTX is in a short-term downtrend within an intact long-term uptrend, with price below both the 50 SMA (206.97) and 200 SMA (193.75). Both moving averages have rolled over since early September, confirming medium-term deterioration. RSI at 25.13 is firmly oversold and MACD has been below zero for 21 sessions without a bullish crossover. Price is sitting on the lower Bollinger Band (184.54), a fragile support level; a close below it would target the April 2026 lows around 170-175. The 200 SMA at 193.75 is the key dynamic resistance to reclaim for stabilization. ATR has contracted to 3.84 from 5.40, and while this volatility compression during a downtrend raises bounce risk, it is not yet a confirmed reversal signal.
Market Cap
$250.21B
P/E (TTM)
32.68x
Forward P/E
23.65x
PEG Ratio
2.17
Price/Book
3.77x
EPS (TTM)
$5.68
Forward EPS
$7.85
Dividend Yield
1.56%
Beta
0.29
52-Week High
$226.88
52-Week Low
$155.64
Revenue (2025)
$88,603M
Revenue Growth (2025 YoY)
+9.7%
Gross Profit (2025)
$17,789M
Operating Income (2025)
$9,300M
Operating Margin (2025)
10.5%
Operating Margin (TTM)
12.7%
EBITDA (2025)
$14,946M
Net Income (2025)
$6,732M
Net Income Growth (2025 YoY)
+41%
Net Margin (TTM)
8.3%
Diluted EPS (2025)
$4.96
ROE (TTM)
12.3%
ROA (TTM)
4.2%
Total Assets (2025)
$171,079M
Total Debt (2025)
$39,506M
Net Debt (2025)
$30,469M
Net Debt (Q2 2026)
$29,078M
Stockholders Equity (2025)
$65,245M
Cash (2025)
$7,435M
Cash (Q2 2026)
$8,305M
Goodwill and Intangibles (2025)
$85,188M
Working Capital (2025)
$1,548M
Operating Cash Flow (2025)
$10,567M
Free Cash Flow (2025)
$7,448M
Free Cash Flow (LTM)
~$9.9B
Capital Expenditure (2025)
$3,119M
Dividends Paid (2025)
$3,574M
Net Debt Repayment (2025)
$3,429M
Buybacks (2025)
$50M
Q2 2026 Revenue
$24,708M
Q2 2026 Net Income
$2,139M
Q2 2026 EPS
$1.57
Q2 2026 Operating Margin
11.4%
Q2 2026 Free Cash Flow
$2,820M
Deferred Revenue (Q2 2026)
$22.7B
R&D Investment
~$2.8B
Revenue (TTM)
$93.5B
Net Income (TTM)
$7.74B
Interest Expense (2025)
$1.84B
Pension/OPEB Liabilities
$5.4B
Asset Sale Proceeds (2025)
$1.93B
Strengths
Concerns
RTX Corporation is a major aerospace and defense conglomerate operating through Collins Aerospace, Pratt & Whitney, and Raytheon segments, serving both commercial aerospace and government defense markets. The company reported strong fundamental improvement in 2025 with revenue of $88.6B (+9.7% YoY), operating margins expanding to 10.5%, net income of $6.7B (+41% YoY), and free cash flow of $7.45B (nearly doubled from 2024). Q2 2026 set quarterly records with $24.7B revenue and $1.57 EPS (+29% YoY). The company is actively deleveraging with net debt declining to $29.1B while maintaining a very low beta of 0.29 and a growing dividend. The rating is HOLD given the stock trades near its 52-week high at premium TTM valuations (P/E 32.7x, PEG 2.17) with limited near-term upside despite the strong fundamental trajectory.
Macro: The macro backdrop is unambiguously hostile for rate-sensitive assets: 30-year Treasury at highest level since 2002, 10-year near 5%, mortgage rates at 7.58% approaching 3-year high. Fed pricing 97% probability of no rate cuts in 2026 ($8.7M Polymarket volume). Moody's Zandi warns higher rates are already damaging the economy. US recession odds remain low at 8% by end-2026. Cooler-than-expected CPI print provided brief equity relief. September was negative for major indices; tech led relief rally but driven by soft macro data, not improving fundamentals. Soft-landing remains dominant priced outcome. Geopolitically, Russia-Ukraine ceasefire odds fading (14%, -8.5pp WoW), Israel tensions elevated (78%), and Strait of Hormuz concerns reinforce defense spending tailwinds.